The first United Urology Group Annual Conference (UUGAC) since United Urology Group (UUG) and OneOncology  joined forces in October 2024 marked a significant milestone in integrated specialty care. With nearly 200 attendees, the two-day event fostered meaningful connections between UUG and OneOncology stakeholders, centered around enticing content spanning policy updates, clinical innovations, and oncology-urology synergies.

Strength in Integration

A core theme of the conference was the strength both organizations have gained through integration over the past year. Highlights include:

Collaboration: The integration of urologists into OneOncology’s medical oncology partner practices—and vice versa— has streamlined the continuum of care for patients and fostered cross-specialty collaboration.

Clinical Synergy: Ancillary services are expanding to meet both urological and oncological needs, with radiation oncology emerging as a key bridge between the two specialties.

Growth: The strength of this collaboration and clinical synergy is driving meaningful growth, enabling economies of intelligence that enhance scale and continuously improve patient care across the community.

Together, these developments reinforce OneOncology’s thesis on Urology and Oncology: that interconnected care leads to smoother patient experiences, faster diagnoses, shared decision-making, and more efficient outcomes. The appointment of Ian Wong, former CEO of UUG, as OneOncology’s new Chief Operations Officer further underscores the commitment to supporting urology practices nationwide.

Conference Highlights

The conference featured nine educational sessions designed to equip community urologists with the latest insights and tools to navigate evolving care landscapes. Topics included:

Genitourinary Cancer Care: Updates on investigational radiochemicals, new drug approvals, and clinical trials—particularly in BCG-unresponsive and high-risk non-muscle invasive bladder cancer—as well as the emerging role of minimal residual disease (MRD) in cancer care.

Benign Prostatic Hyperplasia (BPH): A look at the evolution of BPH treatment and future innovations such as personalized medicine, nanotherapies, and histotripsy.

Policy Updates: Dr. Jonathan Rubenstein, National Director of Coding Compliance, provided insights into the 2026 Proposed Rule and its implications for care delivery. Key changes include a payment shift incentivizing procedures to be performed in office settings rather than facility settings, updates to work RVUs, and revisions to supply packs, CPT codes, and ASC-covered procedures.

Ambulatory Surgical Centers (ASCs): A forward-looking discussion on trends shaping the ASC industry, including technology, staffing, leadership, anesthesia, and regulatory challenges.

Pathology and IOD Innovations: Short- and long-term pathology lab operations projects, as well as a review of novel technologies like nucleus cabinets, IOD injections, and patient engagement at the point of care.

Radiopharmaceuticals: Dr. Todd Doyle of NYOH shared his Radiopharmaceutical Therapy Start-Up Process, preparing practices for the growing number of clinical trials and updates in this space.

Looking Ahead

As UUG and OneOncology continue to deepen their collaboration, partner practices will be increasingly equipped to deliver high-quality, integrated care—no matter the challenges ahead. UUGAC 2026 promises to be another energizing and impactful event for community care.

For more information, contact the Events team at events@oneoncology.com.